SCHEMBL9978734

SCHEMBL9978734

CCc1cc(I)cnc1Br

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
GABRA1 P14867 2/20 0.32
GABRB2 P47870 2/20 0.32
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31
GABRA6 Q16445 1/20 0.31
GABRG1 Q8N1C3 1/20 0.31
GABRG3 Q99928 1/20 0.31
GABRQ Q9UN88 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15289009 0.79 TKT (0.32)
SCHEMBL17502182 0.78 HTT (0.41) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL17315814 0.77 NOS3 (0.39) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL21207982 0.75 NOS3 (0.34) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL5729063 0.75 NOS3 (0.42) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL1460853 0.75 TKT (0.43) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL8214780 0.75 NOS3 (0.34) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL15163966 0.74 HMGCR (0.43)
SCHEMBL13556463 0.73 PTGER4 (0.36) NOS3NOS1NOS2GABRA1GABRB2
SCHEMBL15153985 0.72 FDPS (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576576-A1 HETEROCYCLYL-PYRIDINYL-BASED BIPHOSPHONIC ACID, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF The Royal Institution for the Advancement of Learning/McGill University (CA) 2013-04-10 EP disclosed
WO-2011147038-A1 HETEROCYCLYL-PYRIDINYL-BASED BIPHOSPHONIC ACID, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2011-12-01 WO disclosed